SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Izzy who wrote (2544)10/28/1997 4:41:00 PM
From: JOHN W.  Read Replies (1) | Respond to of 6136
 
It will only get worse when they have to compete world wide with Viracept. Here was the downgrade on MRK that mentions the Agouron success:
biz.yahoo.com



To: Izzy who wrote (2544)10/29/1997 9:42:00 AM
From: Henry Niman  Read Replies (4) | Respond to of 6136
 
Izzy, LGND has been any thing but flat. After dropping to 13 1/2 yesterday (from its 52-week high of 18 3/8 a few weeks ago), it's moved to 15 1/2 this morning. There's another nice article on Biotechs at:
investor.msn.com

Of course LGND's is his #1 choice.